Emerging platforms using liquid biopsy to detectEGFRmutations in lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging platforms using liquid biopsy to detectEGFRmutations in lung cancer
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 15, Issue 11, Pages 1427-1440
Publisher
Informa UK Limited
Online
2015-09-30
DOI
10.1586/14737159.2015.1094379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 36O * DETECTION OF EGFR T790M MUTATION IN URINARY CIRCULATING TUMOR DNA FROM METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS
- (2015) H. Husain et al. ANNALS OF ONCOLOGY
- COUNTERPOINT: Should Lung Cancer Screening by Chest CT Scan Be a Covered Benefit? No
- (2015) Katherine Courtright et al. CHEST
- Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
- (2015) M. Watanabe et al. CLINICAL CANCER RESEARCH
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninvasive Saliva-basedEGFRGene Mutation Detection in Patients with Lung Cancer
- (2014) Fang Wei et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
- (2014) E. L. Diamond et al. BLOOD
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
- (2014) M. Qiu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Double-stranded DNA in exosomes: a novel biomarker in cancer detection
- (2014) Basant Kumar Thakur et al. CELL RESEARCH
- Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
- (2014) Shuai Wang et al. CLINICA CHIMICA ACTA
- Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
- (2014) S. Couraud et al. CLINICAL CANCER RESEARCH
- Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
- (2014) Angela Alama et al. DRUG DISCOVERY TODAY
- Identification of Double-stranded Genomic DNA Spanning All Chromosomes with MutatedKRASandp53DNA in the Serum Exosomes of Patients with Pancreatic Cancer
- (2014) Christoph Kahlert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- (2014) Yi-Long Wu et al. LANCET ONCOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Microfluidic, marker-free isolation of circulating tumor cells from blood samples
- (2014) Nezihi Murat Karabacak et al. Nature Protocols
- Cost-Effectiveness of CT Screening in the National Lung Screening Trial
- (2014) William C. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
- (2014) Antonio Marchetti et al. PLoS One
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients
- (2014) Xuefei Li et al. Translational Oncology
- Prospective Blinded Study of BRAF V600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders
- (2014) David M. Hyman et al. Cancer Discovery
- Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
- (2014) Jie Luo et al. Scientific Reports
- Next-Generation Sequencing Platforms
- (2013) Elaine R. Mardis Annual Review of Analytical Chemistry
- Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor
- (2013) Kazuko Sakai et al. CANCER SCIENCE
- The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
- (2013) Yahya Elshimali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
- (2013) Xiaoqing Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
- (2013) Hye-Ryoun Kim et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer
- (2013) B Jiang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
- (2013) Seung Tae Kim et al. MEDICAL ONCOLOGY
- Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data
- (2013) Yoji Kukita et al. PLoS One
- Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)
- (2013) Dario de Biase et al. PLoS One
- ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood
- (2012) Vishal Gupta et al. Biomicrofluidics
- Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation
- (2012) Ming Xian Lin et al. BIOSENSORS & BIOELECTRONICS
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
- (2012) J. Haroche et al. BLOOD
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
- (2012) Tobias M Gorges et al. BMC CANCER
- Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
- (2012) E. A. Punnoose et al. CLINICAL CANCER RESEARCH
- BEAMing Up Personalized Medicine: Mutation Detection in Blood
- (2012) A. L. Richardson et al. CLINICAL CANCER RESEARCH
- First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
- (2012) Ji-Youn Han et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Electric Properties of Human Breast Cancer Cells
- (2012) Izabela Dobrzyńska et al. JOURNAL OF MEMBRANE BIOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage IIV Non-Small Cell Lung Cancer Patients
- (2012) Xiao Zhao et al. RESPIRATION
- The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI
- (2012) Zhen Huang et al. Thoracic Cancer
- Salivary biomarker development using genomic, proteomic and metabolomic approaches
- (2012) Nicolai J Bonne et al. Genome Medicine
- Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
- (2011) Paul Workman et al. CANCER CELL
- EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
- (2011) Jean-Charles Soria et al. CANCER TREATMENT REVIEWS
- Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
- (2011) K. Taniguchi et al. CLINICAL CANCER RESEARCH
- Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer
- (2011) Koichi Goto et al. Journal of Thoracic Oncology
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- (2011) Matthew G. Krebs et al. Journal of Thoracic Oncology
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- (2010) G. Badalian-Very et al. BLOOD
- Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer
- (2010) Victor Cohen et al. CANCER
- Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
- (2010) V. Hofman et al. CLINICAL CANCER RESEARCH
- Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
- (2010) Véronique Hofman et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells: Will They Be Clinically Useful?
- (2010) N. J. Nelson JNCI-Journal of the National Cancer Institute
- Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
- (2010) Marie Brevet et al. LUNG CANCER
- Saliva: diagnostics and therapeutic perspectives
- (2010) N Spielmann et al. ORAL DISEASES
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
- (2010) S. L. Stott et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of Mutated K-rasDNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps
- (2009) Ying-Hsiu Su et al. Annals of the New York Academy of Sciences
- Microdevice for the isolation and enumeration of cancer cells from blood
- (2009) Swee Jin Tan et al. BIOMEDICAL MICRODEVICES
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
- (2009) Y. Kuang et al. CLINICAL CANCER RESEARCH
- Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer
- (2009) Chen He et al. INTERNATIONAL JOURNAL OF CANCER
- Isolation of tumor cells using size and deformation
- (2009) Hisham Mohamed et al. JOURNAL OF CHROMATOGRAPHY A
- Sequencing technologies — the next generation
- (2009) Michael L. Metzker NATURE REVIEWS GENETICS
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started